Clinical trial
Use of the Synthetic Hormone CDB-2914 in Treating Symptoms of Menopause
NCT00009659 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH · Completed
Key facts
| NCT number | NCT00009659 |
|---|---|
| Title | Use of the Synthetic Hormone CDB-2914 in Treating Symptoms of Menopause |
| Official title | Biologic Activity of a Selective Progesterone Receptor Modulator, CDB-2914, in Post-Menopausal Women |
| Lead sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Postmenopause |
| Intervention type | Drug |
| Interventions | CDB 2914 |
| Enrollment | 58 |
| Start date | Jan 1, 2001 |
| Completion | Dec 1, 2001 |
| First posted | Feb 5, 2001 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: